- Saving the heart after cancer treatmentFeb 9, 2015
- Baylor experts say early screening and monitoring using echocardiograms could be the key to helping cancer survivors stay heart healthy.
- Grant allows development of 'freeze-frame' proteins to study DNAJan 30, 2015
- Baylor College of Medicine's Dr. Susan Rosenberg and colleagues awarded three-year $2 million grant from W.M. Keck Foundation.
- First comprehensive Lung Institute in Texas offers hope along with world class team of experts Jan 16, 2015
- Baylor College of Medicine and Baylor St. Luke’s Medical Center have developed the first comprehensive, multi-specialty Lung Institute in the state of Texas.
- Grant supports research on potential immunotherapy treatment for neuroblastomaDec 30, 2014
Dr. Leonid Metelitsa, named among inaugural recipients of the Bio-therapeutics Impact Award from Alex’s Lemonade Stand.
- Obesity, acid reflux precursors for esophageal cancerDec 29, 2014
New review examines latest developments in the risk factors, pathologies, diagnosis and treatment of esophageal cancers.
- Dr. Trey Westbrook named TAMEST 2015 Edith and Peter O’Donnell Award winner in medicine Dec 9, 2014
- Baylor College of Medicine researcher Dr. Thomas “Trey” Westbrook tapped for prestigious honor given annually to one scientist across the state of Texas for outstanding innovation in medicine.
- New study identifies first gene associated with familial gliomaDec 7, 2014
- Baylor-led research identifies for the first time a gene associated with familial glioma, brain tumors that appear in two or more members of the same family.
- 'Wound response' of cancer stem cells may explain chemo-resistance in bladder cancerDec 3, 2014
- A novel mechanism – similar to how normal tissue stem cells respond to wounding – might explain why bladder cancer stem cells actively contribute to chemo-resistance after multiple cycles of chemotherapy drug treatment.
- Baylor College of Medicine awarded additional $9.9 million in state cancer funding Nov 20, 2014
- Researchers in the NCI-designated Dan L. Duncan Cancer Center at Baylor College of Medicine have been awarded an additional $9.9 million in grant funding from the Cancer Prevention and Research Institute of Texas.
- TopBP1 a sweet spot for treatment in multiple cancersNov 17, 2014
- A compound called calcein may act to inhibit topoisomerase IIβ-binding protein 1 (TopBP1), which enhances the growth of tumors, said researchers from Baylor College of Medicine.